Business strategy

100-crore Milestone Achieved Through Made-in-India Covid Vaccines: Dr VK Paul

As the total Covid-19 vaccine doses administered in India crossed the 100-crore milestone, Covid taskforce chief Dr VK Paul said on Thursday this was a remarkable feat and had been achieved through the vaccines manufactured in India. Paul, also a Niti Aayog member, further said this was an unusual feat and had been achieved in the short period of just nine months of the vaccination programme.

FOLLOW | Coronavirus LIVE Updates: India Scripts History, Tweets PM Modi on 100 Crore Vaccine Feat, Expresses Gratitude to Doctors, Nurses

“Today, India has achieved a landmark milestone. One hundred crore doses, 1 billion doses of Covid-19 vaccines have been administered in our nation,” he told PTI. “What is even more remarkable is that this has been achieved through the vaccines which have been manufactured in India,” he added.

Dr Paul, who has been playing a key role in the government’s efforts in the fight against the coronavirus pandemic further said, going forward, there is need to ensure that those adults who are eligible for vaccine, must receive their first dose and these are 25 per cent of our adult population. “We must ensure individuals whose second dose of vaccine is due, may please take the dose. Without second dose, immunisation is not complete, you are not fully protected.

READ EXCLUSIVE | Billion on the Board: Six People Who Steered World’s Largest Vaccination Drive

“India is not fully protected till complete immunisation is achieved of all adult individuals of our nation,” he emphasised. The cumulative COVID-19 vaccine doses administered in the country surpassed the 100-crore milestone on Thursday.

ALSO READ | Jabs That Did the Trick: A Look at India’s Vaccine Arsenal That Helped it Achieve a Billion-Dose Feat

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *